Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.

Li X, Qi Y, Ma X, Huang F, Guo H, Jiang X, Hong J, Lin D, Cui B, Ning G, Xu L, Wang S.

PLoS One. 2013 May 22;8(5):e64277. doi: 10.1371/journal.pone.0064277. Print 2013.

2.

Increased chemokine (C-C motif) ligand 21 expression and its correlation with osteopontin in Graves' disease.

Qi Y, Li X, Zhang Q, Huang F, Lin D, Zhou Y, Hong J, Cui B, Wang W, Ning G, Wang S.

Endocrine. 2015 Sep;50(1):123-9. doi: 10.1007/s12020-015-0552-7. Epub 2015 Mar 15.

PMID:
25771884
3.

The role of osteopontin in the induction of the CD40 ligand in Graves' disease.

Qi Y, Li X, Ma X, Xu L, Zhang X, Jiang X, Hong J, Cui B, Ning G, Wang S.

Clin Endocrinol (Oxf). 2014 Jan;80(1):128-34. doi: 10.1111/cen.12229. Epub 2013 Jun 3.

PMID:
23617736
4.

The expression and pathophysiological role of osteopontin in Graves' disease.

Xu L, Ma X, Wang Y, Li X, Qi Y, Cui B, Li X, Ning G, Wang S.

J Clin Endocrinol Metab. 2011 Nov;96(11):E1866-70. doi: 10.1210/jc.2011-1339. Epub 2011 Sep 7.

PMID:
21900386
5.

Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells.

Li Y, Wang Z, Yu T, Chen B, Zhang J, Huang K, Huang Z.

PLoS One. 2014 Sep 16;9(9):e107183. doi: 10.1371/journal.pone.0107183. eCollection 2014.

6.

Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.

Zheng W, Li R, Pan H, He D, Xu R, Guo TB, Guo Y, Zhang JZ.

Arthritis Rheum. 2009 Jul;60(7):1957-65. doi: 10.1002/art.24625.

7.

The role of the IL-23/IL-17 axis in the pathogenesis of Graves' disease.

Zheng L, Ye P, Liu C.

Endocr J. 2013;60(5):591-7. Epub 2013 Jan 17.

8.

Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.

Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T.

Gut. 2005 Sep;54(9):1254-62.

9.

Osteopontin: participation in inflammation or mucosal protection in inflammatory bowel diseases?

Chen F, Liu H, Shen Q, Yuan S, Xu L, Cai X, Lian J, Chen SY.

Dig Dis Sci. 2013 Jun;58(6):1569-80. doi: 10.1007/s10620-012-2556-y. Epub 2013 Jan 30.

PMID:
23361573
10.

Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.

Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK.

Rheumatology (Oxford). 2008 Dec;47(12):1775-9. doi: 10.1093/rheumatology/ken385. Epub 2008 Oct 14.

PMID:
18854347
11.

Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.

Chu M, Yang P, Hu R, Hou S, Li F, Chen Y, Kijlstra A.

Invest Ophthalmol Vis Sci. 2011 Sep 9;52(10):7084-9. doi: 10.1167/iovs.11-7539.

PMID:
21810982
12.

Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.

Song RH, Yu ZY, Qin Q, Wang X, Muhali FS, Shi LF, Jiang WJ, Xiao L, Li DF, Zhang JA.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):4024-31. eCollection 2014.

13.

Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.

Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.

Eur J Immunol. 2009 Sep;39(9):2525-36. doi: 10.1002/eji.200838879.

14.

Regulatory T cells in Graves' disease.

Pan D, Shin YH, Gopalakrishnan G, Hennessey J, De Groot LJ.

Clin Endocrinol (Oxf). 2009 Oct;71(4):587-93. doi: 10.1111/j.1365-2265.2009.03544.x. Epub 2009 Feb 16.

PMID:
19222488
16.

Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.

Kamijo K, Murayama H, Uzu T, Togashi K, Olivo PD, Kahaly GJ.

Thyroid. 2011 Dec;21(12):1295-9. doi: 10.1089/thy.2011.0056. Epub 2011 Nov 8.

PMID:
22066477
18.

Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.

Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sørensen ES.

Scand J Immunol. 2007 May;65(5):453-60.

19.

Association between circulating full-length osteopontin and IFN-gamma with disease status of tuberculosis and response to successful treatment.

Ridruechai C, Sakurada S, Yanai H, Yamada N, Kantipong P, Piyaworawong S, Dhepakson P, Khusmith S, Keicho N.

Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):876-89.

PMID:
22299470
20.

High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis.

Koguchi Y, Kawakami K, Uezu K, Fukushima K, Kon S, Maeda M, Nakamoto A, Owan I, Kuba M, Kudeken N, Azuma M, Yara S, Shinzato T, Higa F, Tateyama M, Kadota J, Mukae H, Kohno S, Uede T, Saito A.

Am J Respir Crit Care Med. 2003 May 15;167(10):1355-9. Epub 2003 Feb 5.

PMID:
12574077

Supplemental Content

Support Center